Missouri’s 340B Contract Pharmacy Access Law Takes Effect Tomorrow as More Drugmakers Restore Discounts, Others Sue State

Missouri's law prohibiting drugmaker 340B contract pharmacy restrictions takes effect Aug. 28.
Missouri’s new law prohibiting drugmaker 340B contract pharmacy restrictions takes effect tomorrow, and the drug industry has responded with more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Kedrion Posts 340B Refund Notice; Mylan Issue NDC Changes

Kedrion was one of two drugmakers to issue recent notices to covered entities on a federal government agency website.
Drugmaker Kedrion Biopharma has posted a refund notice to 340B providers, and Mylan notified covered entities of National Drug Code [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

J&J Announces Plans to Shift Certain 340B Discounts to Rebate Model, Prompting Fierce Backlash from Providers, Regulators

Johnson & Johnson announced it will convert two 340B drugs to a rebate model for hospitals.
In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sanofi Asks 340B Hospitals for Information on Purchases of Its Top-Selling Drug

Sanofi is reportedly asking hospitals for data relating to 340B purchases of Dupixent.
French drugmaker Sanofi has reportedly asked some hospitals for data relating to 340B purchases of a popular drug used to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: New Intervenor in Arkansas; Consolidated Cases in Maryland

Key filings and orders occurred in lawsuits challenging the 340B contract pharmacy access law in Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups ask Supreme Court to Reverse Ruling that Impacts 340B Eligibility

Hospital groups are urging the Supreme Court to correct what they called HHS' misinterpretation of DSH percentage calculations.
Six national hospital associations recently urged the Supreme Court to correct what they called the Department of Health and Human [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry-funded Think Tank Raises Questions About 340B Hospitals’ Charity Care

The Pioneer Institute for Public Policy Research compared 29 financially strong 340B hospitals/health systems’ performance on charity care in an Aug. 19 brief.
More transparency surrounding 340B hospital operations is needed to ensure drug discount savings are being used to improve patient care, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Grants Texas Hospitals’ Request to Temporarily Block DSH Calculation Changes

A federal court sided with a group of Texas hospitals’ efforts to block an HHS rule.
A federal court last week sided with a group of Texas hospitals’ efforts to block—at least temporarily—a Department of Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Raises ‘Serious Concerns’ with MedPAC’s Direction on 340B

American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Organon Partially Exempts Missouri, Minnesota Providers from 340B Contract Pharmacy Restrictions

Organon partially exempted covered entities in two states from its contract pharmacy restrictions.
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, has partially exempted covered entities in Missouri [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live